Pipeline

Our product candidates provide opportunities to control and modify diseases, and strive to address the unmet medical needs of patients and their care partners.

Our Programs

We are rapidly advancing a growing pipeline of siRNA product candidates designed to precisely target and silence disease-associated genes. Our pipeline is currently focused on three principle areas of high unmet need: cardiovascular disease, iron loading anemias and complement-mediated disorders.

Picture1.png (2) Picture1.png (2)